3BBLACKBIO — 3B Blackbio DX Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹9.62bn
- IN₹8.71bn
- IN₹1.42bn
Annual cashflow statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 432 | 353 | 443 | 640 | 770 |
| Depreciation | |||||
| Non-Cash Items | 1.06 | -24.2 | -56.7 | -59.5 | -27.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -66.8 | -135 | -128 | -158 | -269 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 373 | 203 | 270 | 434 | 525 |
| Capital Expenditures | -22.6 | -20.2 | -5.08 | -9.04 | -255 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -262 | 168 | -198 | -329 | 19.2 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -284 | 147 | -203 | -338 | -236 |
| Financing Cash Flow Items | -1.34 | -1.25 | -3.23 | -1.08 | 0.984 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -151 | -50.1 | -36.3 | -32.2 | -5.24 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -61.9 | 303 | 29.4 | 66.8 | 318 |